These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative assessment of intravenous regional limb perfusion of tiludronate as an adjunctive treatment for lameness caused by navicular syndrome in horses. Schoonover MJ, Whitfield CT, Young JM, Sippel KM, Payton ME. Am J Vet Res; 2018 Dec; 79(12):1313-1320. PubMed ID: 30457899 [Abstract] [Full Text] [Related]
3. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. Erkert RS, MacAllister CG, Payton ME, Clarke CR. Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129 [Abstract] [Full Text] [Related]
5. Shoeing principles for the management of navicular disease in horses. Turner TA. J Am Vet Med Assoc; 1986 Aug 01; 189(3):298-301. PubMed ID: 3744989 [Abstract] [Full Text] [Related]
6. [Navicular disease in the hind limb of a Warmblood horse]. Meijer MC, Rijkenhuizen AB. Tijdschr Diergeneeskd; 1999 Sep 15; 124(18):536-8. PubMed ID: 10522350 [Abstract] [Full Text] [Related]
8. Diagnosis and treatment of the navicular syndrome in horses. Turner TA. Vet Clin North Am Equine Pract; 1989 Apr 15; 5(1):131-44. PubMed ID: 2650827 [Abstract] [Full Text] [Related]
9. Short-term effect of therapeutic shoeing on severity of lameness in horses with chronic laminitis. Taylor D, Hood DM, Wagner IP. Am J Vet Res; 2002 Dec 15; 63(12):1629-33. PubMed ID: 12492275 [Abstract] [Full Text] [Related]
10. Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness. Hu HH, MacAllister CG, Payton ME, Erkert RS. J Am Vet Med Assoc; 2005 Feb 01; 226(3):414-7. PubMed ID: 15702692 [Abstract] [Full Text] [Related]
12. Injection of corticosteroids, hyaluronate, and amikacin into the navicular bursa in horses with signs of navicular area pain unresponsive to other treatments: 25 cases (1999-2002). Dabareiner RM, Carter GK, Honnas CM. J Am Vet Med Assoc; 2003 Nov 15; 223(10):1469-74. PubMed ID: 14627099 [Abstract] [Full Text] [Related]
13. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses. Keegan KG, Messer NT, Reed SK, Wilson DA, Kramer J. Am J Vet Res; 2008 Feb 15; 69(2):167-73. PubMed ID: 18241011 [Abstract] [Full Text] [Related]
15. Force platform evaluation of lameness severity following extracorporeal shock wave therapy in horses with unilateral forelimb lameness. Dahlberg JA, McClure SR, Evans RB, Reinertson EL. J Am Vet Med Assoc; 2006 Jul 01; 229(1):100-3. PubMed ID: 16817722 [Abstract] [Full Text] [Related]
16. The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses. Back W, MacAllister CG, van Heel MC, Pollmeier M, Hanson PD. Equine Vet J; 2009 Mar 01; 41(3):309-12. PubMed ID: 19469242 [Abstract] [Full Text] [Related]